Loading…
Health Catalyst, Inc. is projected to rise to $1.50 by 2027, a +15% move from its current price of $1.30. HCAT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.24 | $1.30 | $1.36 | 0.00% |
| May 30 | $1.22 | $1.30 | $1.39 | 0.00% |
| May 31 | $1.20 | $1.30 | $1.41 | 0.00% |
| Jun 1 | $1.19 | $1.30 | $1.42 | 0.00% |
| Jun 2 | $1.17 | $1.30 | $1.44 | 0.00% |
| Jun 3 | $1.16 | $1.30 | $1.45 | 0.00% |
| Jun 4 | $1.15 | $1.30 | $1.47 | 0.00% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.15 | $1.30 | $1.47 | 0.00% |
| Week 2 | $1.10 | $1.30 | $1.54 | 0.00% |
| Week 3 | $1.05 | $1.30 | $1.60 | 0.00% |
| Week 4 | $1.02 | $1.30 | $1.66 | 0.00% |
| Week 5 | $0.9917 | $1.30 | $1.70 | 0.00% |
| Week 6 | $0.9664 | $1.30 | $1.75 | -0.01% |
| Week 7 | $0.9437 | $1.30 | $1.79 | -0.01% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services.
It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications built for ignite platform to analyze clients across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics.
The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities.
The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
Health Catalyst, Inc. (HCAT) is a healthcare data analytics company. The current price is $1.29. Its market capitalization is $95.32M and it holds a rank of 4255.
The price outlook is captured in a multi-year forecast, showing movement from the current level toward higher average prices in coming years, with 2026 average forecast at $1.29 and a max of $1.66, and a long-run uptrend culminating in a 2050 average forecast of $4.13 and a max of $9.51.
Forecasted returns vary by year, beginning with 2026 at 0% ROI and moving to higher ROI in subsequent years, reaching 220.4% by 2050. The sentiment signals switch from NEUTRAL in early years to BULLISH in later periods.
A major floor 28.7% below — a decisive break under it would weaken the trend.
The nearest floor, 10.0% below — buyers have tended to step in here.
The nearest ceiling, 23.1% above — a clean break opens room to run.
A major ceiling 81.5% above — clearing it would confirm fresh momentum.
Key HCAT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HCAT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.29 | Buy | $1.29 | Buy |
| MA 10 | $1.27 | Buy | $1.30 | Sell |
| MA 20 | $1.37 | Sell | $1.32 | Sell |
| MA 50 | $1.26 | Buy | $1.40 | Sell |
| MA 100 | $1.65 | Sell | $1.66 | Sell |
| MA 200 | $2.26 | Sell | $2.31 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.94 | Neutral |
| Stoch RSI (14) | 32.15 | Neutral |
| CCI (20) | -36.89 | Neutral |
| Williams %R (14) | -69.05 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -14.47 | Sell |
| Bollinger %B (20,2) | 0.38 | Neutral |
| Stochastic %K (14) | 30.95 | Neutral |
| TRIX (15) | 0.02 | Buy |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 63.98 | Neutral |
| Momentum (10) | -0.18 | Sell |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 1.29 | Buy |
| ADX (14) | 13.48 | Neutral |
| ATR (14) | 0.05 | Info |
The 30-day technical picture is NEUTRAL.
RSI14 is 50. The 50-day simple moving average is $1.26 (SMA50) and the 200-day simple moving average is $2.28 (SMA200).
Support is at $1.06 and resistance at $1.60. The thirty-day price range runs from $0.9408 to $1.77, reflecting modest price movement within the current area.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.996 | $1.30 | $1.66 | 0% | Neutral | |
| $1.11 | $1.50 | $2.18 | +15% | Neutral | |
| $1.18 | $1.67 | $2.57 | +29% | Bullish | |
| $1.30 | $1.93 | $3.09 | +48% | Bullish | |
| $1.23 | $1.89 | $3.14 | +46% | Bullish | |
| $0.9621 | $1.53 | $2.62 | +18% | Neutral | |
| $1.03 | $1.70 | $2.98 | +31% | Bullish | |
| $1.16 | $1.97 | $3.54 | +51% | Bullish | |
| $1.30 | $2.28 | $4.20 | +75% | Bullish | |
| $1.39 | $2.51 | $4.72 | +93% | Bullish | |
| $1.56 | $3.24 | $6.65 | +150% | Bullish | |
| $1.92 | $4.26 | $9.79 | +228% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.996 | $1.30 | $1.55 | +0.00% |
| June 2026 | $1.13 | $1.35 | $1.66 | +3.97% |
| July 2026 | $1.08 | $1.30 | $1.64 | -3.83% |
| August 2026 | $1.06 | $1.29 | $1.65 | -0.54% |
| September 2026 | $1.11 | $1.37 | $1.77 | +5.59% |
| October 2026 | $1.08 | $1.35 | $1.77 | -1.32% |
| November 2026 | $0.9972 | $1.25 | $1.66 | -7.12% |
| December 2026 | $0.9806 | $1.24 | $1.66 | -0.94% |
Click any year to see its month-by-month HCAT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, HCAT is projected to trade between $0.996 and $1.66, averaging $1.30 — a potential gain of 0% from today's $1.30. A consolidation phase looks the most probable path here.
Health Catalyst, Inc.'s 2027 outlook centres on $1.50, within a $1.11 to $2.18 range. That is up +15% on the projected 2026 average. That marks a +15% change versus current levels. Price action looks broadly range-bound.
By 2028, HCAT could reach as high as $2.57, with a base case around $1.67 and support toward $1.18 — roughly +29% from $1.30. Buyers look set to stay in control over this stretch.
Expect HCAT to range from $1.30 to $3.09 through 2029. The $1.93 average target implies a +48% move from current prices. That is up +15% on the projected 2028 average. Momentum favours further upside here.
The HCAT price prediction for 2030 points to an average of $1.89 (low $1.23, high $3.14) — a potential gain of +46% on today's $1.30. Buyers look set to stay in control over this stretch.
In 2031, HCAT is projected to trade between $0.9621 and $2.62, averaging $1.53 — a potential gain of +18% from today's $1.30. That is -19% versus the projected 2030 average. Price action looks broadly range-bound.
Health Catalyst, Inc.'s 2032 outlook centres on $1.70, within a $1.03 to $2.98 range. That is up +11% on the projected 2031 average. That marks a +31% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, HCAT could reach as high as $3.54, with a base case around $1.97 and support toward $1.16 — roughly +51% from $1.30. Momentum favours further upside here.
Expect HCAT to range from $1.30 to $4.20 through 2034. The $2.28 average target implies a +75% move from current prices. That is up +16% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The HCAT price prediction for 2035 points to an average of $2.51 (low $1.39, high $4.72) — a potential gain of +93% on today's $1.30. Momentum favours further upside here.
In 2040, HCAT is projected to trade between $1.56 and $6.65, averaging $3.24 — a potential gain of +150% from today's $1.30. That is up +29% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Health Catalyst, Inc.'s 2050 outlook centres on $4.26, within a $1.92 to $9.79 range. That is up +31% on the projected 2040 average. That marks a +228% change versus current levels. Momentum favours further upside here.
Investing $1,000 in HCAT today (≈ 769.230769 HCAT) could be worth
$3,275.73
+$2,275.73 (+228%) by 2050 · US Dollar
Based on the average projected HCAT price of $4.26 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HCATwould be worth at today's price.
$1,000 invested in HCAT on May 27, 2025 (≈ 264.550267 HCAT) would be worth
$343.92
-$656.08 (-65.6%) today · 0.34× · US Dollar
Based on a HCAT entry price of $3.78 vs. today's $1.3.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.29 | $1,007.75 | +0.8% |
| 1 month ago | $1.37 | $948.91 | -5.1% |
| 3 months ago | $1.75 | $742.86 | -25.7% |
| 6 months ago | $2.99 | $434.78 | -56.5% |
| 1 year ago | $3.78 | $343.92 | -65.6% |
| All time (5.0y) ago | $53.75 | $24.19 | -97.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HCAT forecast.
Our base-case forecast reaches $2.60 around 2040.
Implied market cap at $2.60: $192.12M
The multi-year forecast shows a mix of neutral and bullish periods with meaningful upside as the years progress. In 2026 the avg price is $1.29 with ROI 0 and NEUTRAL sentiment. In 2027 the avg is $1.47 with ROI 14.2 and NEUTRAL sentiment, followed by a bullish shift in 2028 where the avg is $1.66 with ROI 28.5 and bullish sentiment.
By 2029 the avg rises to $1.93 with ROI 49.6 and bullish sentiment, and 2030 shows an avg of $1.87 with ROI 44.8 and bullish sentiment. The path continues with 2031 at $1.48 (ROI 15.1, NEUTRAL), 2032 at $1.68 (ROI 30.3, BULLISH), 2033 at $1.92 (ROI 48.9, BULLISH), 2034 at $2.22 (ROI 72.3, BULLISH), and 2035 at $2.49 (ROI 93.3, BULLISH).
Looking further out, 2040 shows an avg of $3.18 with ROI 146.5 and BULLISH sentiment, and 2050 shows an avg of $4.13 with max $9.51 and ROI 220.4, also with BULLISH sentiment. These figures are estimates, not guarantees, and depend on future market conditions.
Tap a question to reveal the answer.
In 2030 the forecast shows min $1.20, avg $1.87, max $3.15 with ROI 44.8% and sentiment BULLISH.
The forecast includes neutral and bullish years, with average prices rising from $1.29 in 2026 to $4.13 by 2050 and ROI up to 220.4% by 2050. Not all periods are bullish, and these are estimates, not guarantees.
Yes. The 2040 max is $6.66 and the 2050 max is $9.51, indicating potential for prices above $4 in later years.
Current price is $1.29 and market cap is $95.32M. The stock ranks 4255.
Sentiment is NEUTRAL; RSI14 is 50. SMA50 is $1.26 and SMA200 is $2.28. Support is $1.06 and resistance is $1.60. The thirty-day range is $0.9408 to $1.77, and annualized volatility is 90.
Health Catalyst, Inc. Community Discussion
0Share your Health Catalyst, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.